This guidance is intended to help healthcare providers integrate CGRP-targeting therapies into their practices.
This potentially reduces the frequency and severity of migraine attacks.
We have known for decades that one of these proteins is CGRP, he said.
Illustration by Julie Bang for Verywell Health
Just over the past few years, we finally have medications that can block this inflammatory protein.
The new CGRP-targeting therapies are used specifically to abort or prevent a migraine, Jones said.
